Key Takeaways
- Standalone revenue to surge ~25-28% in FY26: The core Indian entity is set to outpace consolidated growth, driven by a defense and space order book that has already expanded significantly.
- Canadian subsidiary is the margin anchor: Losses from the Canadian unit are the primary drag on consolidated profitability, with a resolution targeted by September to unlock a path to 10% EBITDA margins.
- BTS is the high-margin growth engine: The Build-To-Specification business, with ~20% EBITDA margins, is on a trajectory to more than double revenue to ₹400-600 crores in 3-4 years, transforming the company's profit profile.
- A ₹210 crore QIP has de-risked the balance sheet: The fundraise was used to repay ₹110 crores of debt, with the remainder allocated for capacity expansion to capture the domestic defense opportunity.
- What to watch next quarter: The execution of a strategic fix for the Canadian subsidiary by the September deadline, and the conversion of new customer qualifications into firm purchase orders.
The Two-Speed Business: Standalone vs. Consolidated
- Standalone growth is accelerating: The Indian entity, which houses the core BTS and EMS operations, is expected to grow at a blended rate of 25% to 28% in FY26, up from 18% in FY25.
- Subsidiaries are a drag on consolidated performance: While standalone revenues grew 18% YoY, subsidiary revenues declined due to softness in certain customer segments, pulling down the consolidated picture.
- Consolidated growth guided at 18-20%: The company expects this rate for FY26, with the standalone entity growing over 25% and the subsidiary level remaining roughly flat.
- The revenue mix is shifting toward higher-margin BTS: The objective is to grow BTS revenue from ~₹175 crores to ₹400-600 crores in 3-4 years, which would significantly lift the blended margin profile.
- BTS margins are structurally superior: Typical EBITDA margins for build-to-spec are around 20%, compared to 10-12% for the build-to-print EMS business.
Mallavarapu: "Your typical EBITDA margin for build-to-spec can be in the range of 20% or so. And whereas on the EMS side of the business, it's more build-to-print, and that is typically in the 10% to 12% level or so."
The Canadian Subsidiary Problem
- The core issue is a cost-revenue mismatch: The Canadian unit carries manpower as its main cost but lacks sufficient revenues to cover it, creating a persistent bleed on consolidated margins.
- A resolution is targeted by September: Management is exploring a couple of strategic options to enable a smooth transition with the customer and ongoing programs while plugging losses in the short term.
- The focus is on stopping the loss, not finding profit: The immediate objective is to eliminate the drag, not to turn the Canadian unit into a profit center.
- The French subsidiary has a different problem: Revenue decline in engineering services, particularly from automotive and space customers, has degraded margins, though the BTS part of the French business remains profitable.
- Cost optimization is underway in France: The focus is on shifting towards defense and aerospace customers to enhance utilization rates and profitability, with a longer-term strategic re-evaluation to come later.
- A 10% consolidated EBITDA margin is contingent on Canada: Management stated this target is definitely possible this year if the Canadian subsidiary problem is solved by the September quarter.
Desikan: "the focus right now is to stop the bleeding in Canada. So the bleeding is basically because we have manpower there which is the main cost, and we do not have sufficient revenues to cover that... the focus is on to stop the bleeding more than looking for profit in Canada."
Order Book & Demand Drivers
- The standalone order book has grown on strong BTS inflows: The increase was driven primarily by defense and space customers in the Build-To-Specification segment.
- The order book horizon has shortened slightly: Firm purchase order visibility from customers has reduced because supply chains are now more stable, though customer forecasts are not included in the reported order book.
- BTS orders execute over 2-2.5 years: EMS orders typically run under 12 months, and engineering services can be even shorter, giving an overall execution timeline of about 15 to 18 months.
- A ₹2,000 crore bidding pipeline is targeted: The company aims to book this amount over the next three to four years, though timelines depend on government procurement processes.
- New customers are in the final qualification stage: Prototyping and NPI phases have been delivered and stress testing is underway, with firm purchase orders expected in the coming quarter or two.
- China Plus One is a tangible tailwind: The company is in advanced stages of qualification with new customers pursuing this strategy and expects more order inflow and revenues this year itself.
Mallavarapu: "we are in advanced stages of qualification with the customers. And we expect this year itself, so there will be more order inflow and revenues coming in from some of these new customers that have been pursuing this China plus One approach."
Business Segment Deep Dive
Build-To-Specification (BTS)
- Space systems are moving up the value chain: The company is transitioning from a niche microelectronic component supplier to delivering full satellite payloads, a capability management claims very few private sector peers can match.
- Radar and defense electronics are a second pillar: The company has built subsystems for critical programs including VL-SRSAM, land systems, missile programs for BDL, and tank electronics including T-90 indigenization.
- An electronic intelligence program is progressing: The first set of engineering models has been delivered to the customer and well received, with work moving to the subsequent phase.
EMS (Build-To-Print)
- The business is anchored by strategic export programs: Key engagements include building critical electronics for Rafale fighter radar and electronic warfare systems, and exporting electronics to the Middle East for missile programs.
- New customer sectors are opening up: The company has added an important customer in semiconductor equipment and is building a partnership in biometric solutions, both of which could become substantial revenue contributors.
Engineering Services
- The French unit faced a dual slowdown: Activity slowed in automotive, impacted by the broader European environment, and in space, which had picked up in FY23/FY24 but slowed significantly in the past 12-18 months.
Mallavarapu: "I would say we have a very strong capability and very few other private sector companies would be able to demonstrate. So, we have quite unique differentiated capabilities, both in terms of design and IP as well as manufacturing capability as far as this goes."
Financial Position & Capital Allocation
- A ₹210 crore QIP was successfully completed: The raise from marquee investors was used to repay ₹110 crores of debt, with remaining funds allocated towards CAPEX and general corporate purposes.
- Working capital increased to 87 days: The rise at the consolidated level was primarily due to higher billings in Q4, a timing issue rather than a structural deterioration.
- Other expenses declined 11% for the full year: This was driven by a specific cost reduction initiative in the subsidiary, including restructuring in manpower and other expenses, because revenues were not growing.
- The reduced cost base is intended to be permanent: Management stated the endeavor is to control expenses at the revised level and not allow an increase.
- ₹40 crores of standalone CAPEX is planned for FY26: The investment will augment capabilities and increase capacities in both BTS and EMS segments.
- A CFO transition is underway: Mr. K.S. Desikan is superannuating after 25 years and is succeeded by Mr. Sundararajan Parthasarathy, who brings 25 years of experience across multiple industries and was most recently the first global CFO of Agratas, a TATA enterprise.
Domestic Opportunity & Strategic Positioning
- Domestic revenue contribution has been rising: The share has increased over the last 3-4 years driven by the Make in India push, with most domestic business coming from BTS.
- The shift will be gradual, not sudden: Management expects a gradual increase in domestic contribution, possibly reaching 35% in the next three years, not a dramatic swing from the current ~29%.
- Industrial opportunities are emerging: The company sees clear opportunities in renewables, grid automation, and electrification, supported by increased national CAPEX for indigenization.
- The company asks to be judged annually, not quarterly: Management cautioned that revenues have some lumpiness and the business is better viewed on a full-year basis.
Mallavarapu: "Please do not look at us as a quarter-by-quarter company, please continue to look at us as a full annualized company because we do have some lumpiness in our revenues."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Standalone revenue growth | Blended growth rate of 25% to 28% across EMS and BTS | FY26 |
| Consolidated revenue growth | 18% to 20% growth, with subsidiary roughly flat | FY26 |
| Canadian subsidiary resolution | Strategic option executed to plug losses | By September or sooner |
| Consolidated EBITDA margin | 10% margin achievable | FY26, contingent on Canada resolution by Q2 |
| BTS revenue scale-up | Grow from ~₹175 crores to ₹400-600 crores | 3-4 years |
| Consolidated revenue CAGR | 18% to 20% CAGR | Next three years |
| Standalone CAPEX | ₹40 crores to augment BTS and EMS capabilities | FY26 |
| New customer conversion | Firm purchase orders from customers in final qualification | Coming quarter or two |
| Domestic revenue mix | Gradual increase, possibly reaching 35% | Next three years |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated revenue | ₹369 cr, +24% YoY and +31% QoQ |
| Standalone revenue | ₹270 cr, +60% YoY and +49% QoQ |
| Consolidated EBITDA | ₹42 cr, +132% YoY and +115% QoQ |
| Consolidated EBITDA margin | 11.31% |
| Standalone EBITDA | ₹47 cr, +175% YoY and +120% QoQ |
| Standalone EBITDA margin | 17.37% |
| Consolidated net profit | ₹22 cr, PAT margin 5.83% |
| Standalone net profit | ₹30 cr, +240% YoY and +225% QoQ |
| FY25 standalone revenue | ₹750 cr, +18.5% YoY |
| FY25 standalone EBITDA margin | 13.6% |
| FY25 standalone net profit | ₹53 cr, +46% YoY |
| Total order book | ₹1,736 cr as of 31 Mar 2025 |
| Standalone order book | ₹1,330 cr, up from ₹1,118 cr at end of FY24 |
| Standalone BTS order book | ₹664 cr |
| Standalone EMS order book | ₹665 cr |
| Consolidated revenue growth guidance | 18% to 20% for FY26 |
| Standalone revenue growth guidance | over 25% for FY26 |
| Consolidated EBITDA margin guidance | ~10% for FY26 |
| Working capital days | 87 days at consolidated level |
| QIP funds raised | ₹210 cr |
| QIP debt repaid | ₹110 cr of ₹115 cr allocated |
| FY26 CAPEX plan | ₹40 cr, standalone, for BTS and EMS |
| Subsidiary revenue FY25 | ₹406 cr, split: BTS ₹187 cr, engineering services ₹280 cr |
| Canadian subsidiary FY25 loss | EUR0.28 cr, similar to ~EUR0.25 cr losses in prior two years |
| Effective tax rate | 26% to 27% on consolidated basis |
| Domestic revenue contribution | ~29% of overall revenues |
| Revenue CAGR target | 18% to 20% for next three years |
| BTS order pipeline target | ₹2,000 cr of bookings over next three to four years |
| BTS typical EBITDA margin | ~20% |
| EMS typical EBITDA margin | 10% to 12% |